Suchergebnisse - "Specchia, Giorgina"

PubPharm (4)

1

The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone : a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase

enthalten in: Haematologica | 2010

von Palandri, F. | Castagnetti, F. | Iacobucci, I. | +17

2

Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements

enthalten in: Molecular cancer | 2010

von Albano, F. | Anelli, L. | Zagaria, A. | +7

3

Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia : a European LeukemiaNet Study

enthalten in: Blood | 2009

von Baccarani, M. | Rosti, G. | Castagnetti, F. | +22

4

Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia : the GIMEMA Working Party on CML

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2008

von Palandri, F. | Iacobucci, I. | Martinelli, G. | +17

1
[1]